Secor Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-11,474
| Closed | -$1.12M | – | 567 |
|
|
2018
Q4 | $1.12M | Buy |
+11,474
| New | +$1.12M | 0.15% | 164 |
|
|
2018
Q2 | – | Sell |
-19,150
| Closed | -$2.13M | – | 612 |
|
|
2018
Q1 | $2.13M | Buy |
+19,150
| New | +$2.13M | 0.18% | 160 |
|
|
2017
Q4 | – | Sell |
-20,995
| Closed | -$2.95M | – | 558 |
|
|
2017
Q3 | $2.95M | Sell |
20,995
-6,159
| -23% | -$864K | 0.28% | 104 |
|
|
2017
Q2 | $3.3M | Buy |
+27,154
| New | +$3.3M | 0.3% | 92 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 557 |
|
|
2016
Q4 | – | Sell |
-25,254
| Closed | -$3.1M | – | 576 |
|
|
2016
Q3 | $3.1M | Buy |
25,254
+19,247
| +320% | +$2.36M | 0.34% | 80 |
|
|
2016
Q2 | $701K | Buy |
+6,007
| New | +$701K | 0.09% | 266 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 731 |
|
|
2015
Q2 | – | Sell |
-5,861
| Closed | -$1.02M | – | 587 |
|
|
2015
Q1 | $1.02M | Buy |
5,861
+3,556
| +154% | +$616K | 0.4% | 54 |
|
|
2014
Q4 | $426K | Buy |
+2,305
| New | +$426K | 0.18% | 215 |
|